AltheaDx Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
45
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$49.1M
AltheaDx General Information
Description
Operator of a commercial-stage molecular diagnostics company intended to specialize in the field of pharmacogenomics. The company's bioinformatics platform and PGx product testing portfolio assist healthcare providers in identifying optimal drugs for their patients as well as dosing guidelines based on a patient's genetic make-up, current prescription regimen and other key factors, enabling healthcare providers to make timely and evidence-based decisions.
Contact Information
Website
www.altheadx.comCorporate Office
- 3030 Bunker Hill Street
- Suite 300
- San Diego, CA 92109
- United States
Corporate Office
- 3030 Bunker Hill Street
- Suite 300
- San Diego, CA 92109
- United States
AltheaDx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 26-Apr-2022 | $49.1M | Completed | Generating Revenue | ||
| 9. Later Stage VC | 04-Dec-2020 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 11-Oct-2019 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 15-Jan-2019 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 09-Aug-2018 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 25-Apr-2017 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 14-Dec-2015 | Completed | Generating Revenue | |||
| 3. IPO | 09-Mar-2015 | Cancelled | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 19-Jun-2013 | $7.25M | $13.2M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 13-Apr-2010 | $6M | $6M | Completed | Generating Revenue |
AltheaDx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D1 | ||||||||
| Series D2 | ||||||||
| Series C | ||||||||
| Series B | 3,954,952 | $0.000100 | $0.08 | $1 | $1 | $2.44 | 0.73% | |
| Series A | 831,923 | $0.000100 | $0.14 | $1.78 | $1.78 | $3.33 | 0.2% |
AltheaDx Comparisons
Industry
Financing
Details
AltheaDx Competitors (11)
One of AltheaDx’s 11 competitors is GeneSight, a Formerly VC-backed company based in Mason, OH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GeneSight | Formerly VC-backed | Mason, OH | ||||
| Zynx Health | Formerly VC-backed | South San Francisco, CA | ||||
| Genome Medical | Venture Capital-Backed | South San Francisco, CA | ||||
| NalaGenetics | Venture Capital-Backed | Singapore, Singapore | ||||
| Fulgent Genetics | Formerly VC-backed | El Monte, CA |
AltheaDx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
AltheaDx Patents
AltheaDx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2012170710-A1 | Disease classification modules | Inactive | 08-Jun-2011 | ||
| US-20090110639-A1 | Predicting vaccine efficacy | Inactive | 07-Jun-2007 | ||
| US-20080124726-A1 | Apparatus which generates single cell aqueous reaction volumes in a flow channel for use detection pf preferential protein expression in cell; high throughput assay | Inactive | 26-May-2006 | ||
| CA-2653321-A1 | Biochemical analysis of partitioned cells | Inactive | 26-May-2006 | ||
| EP-2029781-A2 | Biochemical analysis of partitioned cells | Inactive | 26-May-2006 | G01N33/56966 |
AltheaDx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
AltheaDx Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 120 Capital | Venture Capital | Minority | ||
| ALMA Life Sciences | Venture Capital | Minority | ||
| Ally Bridge Group | Growth/Expansion | Minority | ||
| Biobrit | Venture Capital | Minority | ||
| Angel (individual) | Minority |
AltheaDx FAQs
-
When was AltheaDx founded?
AltheaDx was founded in 2008.
-
Where is AltheaDx headquartered?
AltheaDx is headquartered in San Diego, CA.
-
What is the size of AltheaDx?
AltheaDx has 45 total employees.
-
What industry is AltheaDx in?
AltheaDx’s primary industry is Practice Management (Healthcare).
-
Is AltheaDx a private or public company?
AltheaDx is a Private company.
-
What is the current valuation of AltheaDx?
The current valuation of AltheaDx is .
-
What is AltheaDx’s current revenue?
The current revenue for AltheaDx is .
-
How much funding has AltheaDx raised over time?
AltheaDx has raised $79.8M.
-
Who are AltheaDx’s investors?
120 Capital, ALMA Life Sciences, Ally Bridge Group, Biobrit, and are 5 of 8 investors who have invested in AltheaDx.
-
Who are AltheaDx’s competitors?
GeneSight, Zynx Health, Genome Medical, NalaGenetics, and Fulgent Genetics are some of the 11 competitors of AltheaDx.
-
When was AltheaDx acquired?
AltheaDx was acquired on 26-Apr-2022.
-
Who acquired AltheaDx?
AltheaDx was acquired by Castle Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
